Sign in

GELS on Nasdaq

Gelteq Ltd

Gelteq Ltd is a pharmaceutical preparations company, listed on Nasdaq (GELS).1

Price unavailable

Last updated Oct 21, 2026.

Overview

-6.6MNet income, fiscal 20252

Compare with another stock.

  • TickerGELS on Nasdaq1
  • IndustryPharmaceutical Preparations1
  • HeadquartersC31
  • Incorporated inAustralia3
  • Business addressLevel 4, 100 Albert Road, South Melbourne Vic3
  • Filer categoryNon-accelerated filer, Emerging growth company3

See how the biggest companies compare on our leaderboards

(USD$26,000). We have shipped such orders in the fiscal year ending June 30, 2025 as our clients have resolved their cash flow issues.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-42.0%Return on equity2
0.00×Debt to equity2
-$5.5MFree cash flow2

Financial statements

Operating income52-$5.5M in 2025+77% since 2023
-$6.0M-$4.0M-$2.0M02023: -$3.1M-$3.1M20232024: -$2.9M-$2.9M2024−5%2025: -$5.5M-$5.5M2025+87%
Net income52-$6.6M in 2025+90% since 2023
-$8.0M-$6.0M-$4.0M-$2.0M02023: -$3.5M-$3.5M20232024: -$3.5M-$3.5M2024+1%2025: -$6.6M-$6.6M2025+87%

Every line of the income statement as filed: the last 2 fiscal years, latest first.2

Period ending2025-06-302024-06-30
Revenue from contracts with customers165.6K AUD
Cost of sales-115.4K AUD
Gross profit50.2K AUD
Other income403.4K AUD146.9K AUD
Employment expenses-481.1K AUD-875.6K AUD
Corporate expenses-548.8K AUD-222.6K AUD
IPO related expenses-584.9K AUD-166.8K AUD
Depreciation and amortisation expense-1.2M AUD-1.2M AUD
Research expenses-628.6K AUD-276.1K AUD
Advertising and marketing expense-204.1K AUD-18.2K AUD
Consulting fees-993.7K AUD-750 AUD
Other expenses-1.3M AUD-145.9K AUD
Inventory - write off-175.1K AUD
Operating loss-5.5M AUD-2.9M AUD
Finance costs-2.0M AUD-600.2K AUD
Gain/(loss) on extinguishment499.6K AUD
Gain/(loss) on derivative revaluation301.1K AUD
Loss before income tax expense-6.6M AUD-3.5M AUD
Loss after income tax expense for the year attributable to the owners of Gelteq Limited-6.6M AUD-3.5M AUD
Total comprehensive loss for the year attributable to the owners of Gelteq Limited-6.6M AUD-3.5M AUD
Basic loss per share (in Dollars per share)-0.72 AUD-0.44 AUD
Diluted loss per share (in Dollars per share)-0.72 AUD-0.44 AUD

Compare Gelteq Ltd with another company

What it owns

What Gelteq Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net15.9K AUD2 Jun 30, 202516.6K AUD2 Jun 30, 2024−4.4%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents344.6K AUD2 Jun 30, 202524.5K AUD2 Jun 30, 2024+1305.5%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)19.9M AUD2 Jun 30, 202520.4M AUD2 Jun 30, 2024−2.8%

Leadership

Who has led Gelteq Ltd, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Nathan J. Givoni2026–now
Board members and other officers (3)

Former names

  • Gelteq Pty Ltd.Mar 31, 2022 to Mar 31, 20223

Timeline

  1. Mar 18, 2026New chief executive Nathan J. Givoni becomes CEO6

Filings

71 filings to the SEC since October 2021: 2 annual reports, 4 insider forms, 65 other. The latest 20:

  1. Jul 6, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  2. Jun 30, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  3. Jun 2, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  4. May 26, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  5. Mar 24, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  6. Mar 18, 20263 EDGAR
  7. Mar 18, 20263 EDGAR
  8. Mar 18, 20263 EDGAR
  9. Mar 18, 20263 EDGAR
  10. Dec 9, 20256-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  11. Nov 17, 202520-F ANNUAL REPORT EDGAR
  12. Nov 3, 2025NT 20-F NOTIFICATION OF LATE FILING EDGAR
  13. Aug 29, 2025EFFECT EDGAR
  14. Aug 29, 2025424B3 PROSPECTUS EDGAR
  15. Aug 28, 2025CORRESP EDGAR
  16. Jul 25, 2025F-1/A REGISTRATION STATEMENT EDGAR
  17. Jul 8, 2025UPLOAD EDGAR
  18. Jul 1, 2025F-1 REGISTRATION STATEMENT EDGAR
  19. Jun 30, 20256-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  20. Mar 14, 20256-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR

The 71 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How Gelteq Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARGelteq Ltd1
  • CIK0001920092
  • Filer statusNon-accelerated filer an emerging growth company; not a shell company4
  • Incorporated inAustralia4
  • Fiscal year endsJune 301
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business addressLevel 4, 100 Albert Road, South Melbourne Vic, Australia1
  • Phone613908739901
  • Shares outstanding9,438,075 as of Nov 15, 20245
  • AuditorM&K CPAS, PLLC, Woodlands, TX PCAOB ID 2738; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceMar 31, 20221
  • Filings71 in all: CORRESP (14), F-1/A (11), UPLOAD (11), 6-K (9), 3 (4), EFFECT (3), F-1 (3), 20-F (2)1
    All 20 form types

    NT 20-F (2), SEC STAFF LETTER (2), 424B3 (1), 424B4 (1), 8-A12B (1), AW (1), CERT (1), DRS (1), DRS/A (1), DRSLTR (1), POS AM (1), RW (1)

  • Latest filingsAnnual report (20-F) Nov 17, 2025

Securities registered for trading

ClassSymbolExchange
Ordinary shares, no par valueGELSNasdaq

From the cover page of the 20-F filed Nov 17, 2025 (Section 12(b) of the Exchange Act).4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9